Literature DB >> 22713240

Overexpression of cyclin E/CDK2 complexes overcomes FGF-induced cell cycle arrest in the presence of hypophosphorylated Rb proteins.

Victoria Kolupaeva1, Claudio Basilico.   

Abstract

FGF signaling inhibits chondrocyte proliferation and requires the function of the p107 and p130 members of the Rb protein family to execute growth arrest. p107 dephosphorylation plays a critical role in the chondrocyte response to FGF, as overexpression of cyclin D1/CDK4 complexes (the major p107 kinase) in rat chondrosarcoma (RCS) cells overcomes FGF-induced p107 dephosphorylation and growth arrest. In cells overexpressing cyclin D1/CDK4, FGF-induced downregulation of cyclin E/CDK2 activity was absent. To examine the role of cyclin E/CDK2 complexes in mediating FGF-induced growth arrest, this kinase was overexpressed in RCS cells. FGF-induced dephosphorylation of either p107 or p130 was not prevented by overexpressing cyclin E/CDK2 complexes. Unexpectedly, however, FGF-treated cells exhibited sustained proliferation even in the presence of hypophosphorylated p107 and p130. Both pocket proteins were able to form repressive complexes with E2F4 and E2F5 but these repressors were not translocated into the nucleus and therefore were unable to occupy their respective target DNA sites. Overexpressed cyclin E/CDK2 molecules were stably associated with p107 and p130 in FGF-treated cells in the context of E2F repressive complexes. Taken together, our data suggest a novel mechanism by which cyclin E/CDK2 complexes can promote cell cycle progression in the presence of dephosphorylated Rb proteins and provide a novel insight into the key Retinoblastoma/E2F/cyclin E pathway. Our data also highlight the importance of E2F4/p130 complexes for FGF-mediated growth arrest in chondrocytes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22713240      PMCID: PMC3404882          DOI: 10.4161/cc.20944

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  34 in total

1.  Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression.

Authors:  Y Takahashi; J B Rayman; B D Dynlacht
Journal:  Genes Dev       Date:  2000-04-01       Impact factor: 11.361

2.  Nucleocytoplasmic shuttling of p130/RBL2: novel regulatory mechanism.

Authors:  Anton Chestukhin; Larisa Litovchick; Katherine Rudich; James A DeCaprio
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

3.  E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry.

Authors:  K Moberg; M A Starz; J A Lees
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  E2F4 is exported from the nucleus in a CRM1-dependent manner.

Authors:  S Gaubatz; J A Lees; G J Lindeman; D M Livingston
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

5.  Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF.

Authors:  H S Zhang; M Gavin; A Dahiya; A A Postigo; D Ma; R X Luo; J W Harbour; D C Dean
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

6.  Activating transcription factor 2 is necessary for maximal activity and serum induction of the cyclin A promoter in chondrocytes.

Authors:  F Beier; A C Taylor; P LuValle
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

7.  The subcellular localization of E2F-4 is cell-cycle dependent.

Authors:  G J Lindeman; S Gaubatz; D M Livingston; D Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

8.  Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer.

Authors:  C Müller-Tidow; R Metzger; K Kügler; S Diederichs; G Idos; M Thomas; B Dockhorn-Dworniczak; P M Schneider; H P Koeffler; W E Berdel; H Serve
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

9.  Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2.

Authors:  T Aikawa; G V Segre; K Lee
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

10.  E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control.

Authors:  S Gaubatz; G J Lindeman; S Ishida; L Jakoi; J R Nevins; D M Livingston; R E Rempel
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

View more
  11 in total

1.  Association of SOX4 regulated by tumor suppressor miR-30a with poor prognosis in low-grade chondrosarcoma.

Authors:  Ning Lu; Tao Lin; Lin Wang; Mei Qi; Zhiyan Liu; Hongyan Dong; Xiying Zhang; Chunyan Zhai; Yan Wang; Long Liu; Lei Xiang; Lei Qi; Bo Han; Jinsong Li
Journal:  Tumour Biol       Date:  2015-01-09

2.  Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells.

Authors:  Tsutomu Shimura; Yasushi Ochiai; Naoto Noma; Toshiyuki Oikawa; Yui Sano; Manabu Fukumoto
Journal:  Cell Cycle       Date:  2013-02-06       Impact factor: 4.534

3.  Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1.

Authors:  C Elizabeth Caldon; C Marcelo Sergio; Andrew Burgess; Andrew J Deans; Robert L Sutherland; Elizabeth A Musgrove
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

4.  The oncogenetic role of stanniocalcin 1 in lung adenocarcinoma: a promising serum candidate biomarker for tracking lung adenocarcinoma progression.

Authors:  Yu-Zhen Du; Xiao-Hua Gu; Shao-Fei Cheng; Li Li; Hua Liu; Liu-Ping Hu; Feng Gao
Journal:  Tumour Biol       Date:  2015-11-17

5.  Cell cycle-related kinase in carcinogenesis.

Authors:  Ye Tian; Han Wan; Guang Tan
Journal:  Oncol Lett       Date:  2012-07-27       Impact factor: 2.967

6.  Cyclin E and FGF8 are downstream cell growth regulators in distinct tumor suppressor effects of ANXA7 in hormone-resistant cancer cells of breast versus prostate origin.

Authors:  A Bera; X-M Leighton; H Pollard; M Srivastava
Journal:  Trends Cancer Res       Date:  2018

7.  Fibronectin Promotes the Malignancy of Glioma Stem-Like Cells Via Modulation of Cell Adhesion, Differentiation, Proliferation and Chemoresistance.

Authors:  Qi Yu; Yixue Xue; Jing Liu; Zhuo Xi; Zhen Li; Yunhui Liu
Journal:  Front Mol Neurosci       Date:  2018-04-13       Impact factor: 5.639

8.  Loss of Fibroblast Growth Factor Receptor 2 (FGFR2) Leads to Defective Bladder Urothelial Regeneration after Cyclophosphamide Injury.

Authors:  Sridhar T Narla; Daniel S Bushnell; Caitlin M Schaefer; Mehdi Nouraie; Justin T Tometich; Timothy W Hand; Carlton M Bates
Journal:  Am J Pathol       Date:  2020-12-30       Impact factor: 5.770

9.  Discrepancy between the effects of morronside on apoptosis in human embryonic lung fibroblast cells and lung cancer A549 cells.

Authors:  Jian-Ping Chen; DE-Guo Xu; Xiao-Yi Yu; Feng-Ming Zhao; Dong-Qing Xu; Xu Zhang; Bao-Chang Cai; Ming-Yan Wang
Journal:  Oncol Lett       Date:  2014-02-03       Impact factor: 2.967

10.  Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.

Authors:  Mateusz Opyrchal; Jeffrey L Salisbury; Ianko Iankov; Mathew P Goetz; James McCubrey; Mario W Gambino; Lorenzo Malatino; Giuseppe Puccia; James N Ingle; Evanthia Galanis; Antonino B D'Assoro
Journal:  Int J Oncol       Date:  2014-06-25       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.